{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:37:53Z","timestamp":1776821873366,"version":"3.51.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Council for Scientific and Technological Development (CNPq) and DECIT\/SCTIE\/MS","award":["406694\/2022-2"],"award-info":[{"award-number":["406694\/2022-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42403-4","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:56:25Z","timestamp":1773222985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing"],"prefix":"10.1038","volume":"16","author":[{"given":"Anelis Maria","family":"Marin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branca Engel","family":"Timoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo Dias","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9 Ferreira","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Naccache","family":"Namur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Kusma","family":"Wosniaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Canzian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Blanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalila Luc\u00edola","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus N\u00f3brega","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"42403_CR1","unstructured":"American Cancer Society. Cancer Facts & Figures. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2022\/2022-cancer-facts-and-figures.pdf (2024)."},{"key":"42403_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla, P., Sunkara, T. & Gaduputi, V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J. Oncol. 10, 10\u201327 (2019).","journal-title":"World J. Oncol."},{"key":"42403_CR3","unstructured":"World Health Organization. Cancer today. https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=population&cancers=13&group_populations=0&multiple_populations=1&types=1 (2024)."},{"key":"42403_CR4","unstructured":"Instituto Nacional do C\u00e2ncer. C\u00e2ncer de p\u00e2ncreas. https:\/\/www.gov.br\/inca\/pt-br\/assuntos\/cancer\/tipos\/pancreas (2024)."},{"key":"42403_CR5","doi-asserted-by":"crossref","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic Cancer: A Review. JAMA 326, 851\u2013862 (2021).","DOI":"10.1001\/jama.2021.13027"},{"key":"42403_CR6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D., Surana, R., Valle, J. W. & Shroff, R. T. Pancreatic cancer. Lancet 395, 2008\u20132020 (2020).","journal-title":"Lancet"},{"key":"42403_CR7","unstructured":"Society, A. C. Cancer Facts & Figures - American Cancer Society. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2021\/cancer-facts-and-figures-2021.pdf 1\u201372. (2021)."},{"key":"42403_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2022","unstructured":"Connor, A. A. & Gallinger, S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat. Rev. Cancer. 22, 131\u2013142 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"42403_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41575-021-00463-z","volume":"18","author":"A Hayashi","year":"2021","unstructured":"Hayashi, A., Hong, J. & Iacobuzio-Donahue, C. A. The pancreatic cancer genome revisited. Nat. Rev. Gastroenterol. Hepatol. 18, 469\u2013481 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42403_CR10","first-page":"1801","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones, S. et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses. Sci. (1979). 321, 1801\u20131806 (2008).","journal-title":"Sci. (1979)"},{"key":"42403_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ccell.2018.12.010","volume":"35","author":"AA Connor","year":"2019","unstructured":"Connor, A. A. et al. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Cancer Cell. 35, 267\u2013282e7 (2019).","journal-title":"Cancer Cell."},{"key":"42403_CR12","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1053\/j.gastro.2020.02.059","volume":"158","author":"P Storz","year":"2020","unstructured":"Storz, P. & Crawford, H. C. Carcinogenesis of Pancreatic Ductal Adenocarcinoma. Gastroenterology 158, 2072\u20132081 (2020).","journal-title":"Gastroenterology"},{"key":"42403_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501 (2015).","journal-title":"Nature"},{"key":"42403_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","volume":"142","author":"M Kanda","year":"2012","unstructured":"Kanda, M. et al. Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia. Gastroenterology 142, 730\u2013733e9 (2012).","journal-title":"Gastroenterology"},{"key":"42403_CR15","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1158\/1078-0432.CCR-12-1215","volume":"18","author":"S Yachida","year":"2012","unstructured":"Yachida, S. et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin. Cancer Res. 18, 6339\u20136347 (2012).","journal-title":"Clin. Cancer Res."},{"key":"42403_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350\u2013353 (1996).","journal-title":"Science"},{"key":"42403_CR17","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1158\/0008-5472.CAN-19-1523","volume":"80","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Cancer Res. 80, 2804\u20132817 (2020).","journal-title":"Cancer Res."},{"key":"42403_CR18","doi-asserted-by":"crossref","unstructured":"Lambert, A., Schwarz, L., Ducreux, M. & Conroy, T. Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer. Cancers (Basel) 13(18), 4724, (2021).","DOI":"10.3390\/cancers13184724"},{"key":"42403_CR19","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.eclinm.2022.101747","volume":"55","author":"LNC Boyd","year":"2023","unstructured":"Boyd, L. N. C. et al. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data. EClinicalMedicine 55, 101747 (2023).","journal-title":"EClinicalMedicine"},{"key":"42403_CR20","doi-asserted-by":"publisher","first-page":"217245","DOI":"10.1016\/j.canlet.2024.217245","volume":"604","author":"B Haab","year":"2024","unstructured":"Haab, B. et al. A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. Cancer Lett. 604, 217245 (2024).","journal-title":"Cancer Lett."},{"key":"42403_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41698-022-00345-w","volume":"7","author":"PS Chauhan","year":"2023","unstructured":"Chauhan, P. S. et al. Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients. NPJ Precis Oncol. 7, 6 (2023).","journal-title":"NPJ Precis Oncol."},{"key":"42403_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/clinchem\/hvac122","volume":"68","author":"B Salfer","year":"2022","unstructured":"Salfer, B., Li, F., Wong, D. T. W. & Zhang, L. Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management. Clin. Chem. 68, 1493\u20131501 (2022).","journal-title":"Clin. Chem."},{"key":"42403_CR23","doi-asserted-by":"publisher","first-page":"e0285214","DOI":"10.1371\/journal.pone.0285214","volume":"18","author":"PJ Brooks","year":"2023","unstructured":"Brooks, P. J., Malkin, E. Z., De Michino, S. & Bratman, S. V. Isolation of salivary cell-free DNA for cancer detection. PLoS One. 18, e0285214 (2023).","journal-title":"PLoS One"},{"key":"42403_CR24","doi-asserted-by":"crossref","unstructured":"Salfer, B. et al. Evaluating Pre-Analytical Variables for Saliva Cell-Free DNA Liquid Biopsy. Diagnostics (Basel) 13(10), 1665, (2023).","DOI":"10.3390\/diagnostics13101665"},{"key":"42403_CR25","doi-asserted-by":"crossref","unstructured":"Marin, A. M. et al. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. Biomedicines 11, (2023).","DOI":"10.3390\/biomedicines11041069"},{"key":"42403_CR26","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert, C. et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J. Biol. Chem. 289, 3869\u20133875 (2014).","journal-title":"J. Biol. Chem."},{"key":"42403_CR27","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","volume":"24","author":"BK Thakur","year":"2014","unstructured":"Thakur, B. K. et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell. Res. 24, 766\u2013769 (2014).","journal-title":"Cell. Res."},{"key":"42403_CR28","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr, S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659\u20131665 (2001).","journal-title":"Cancer Res."},{"key":"42403_CR29","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/ajg.2012.288","volume":"107","author":"MA Anderson","year":"2012","unstructured":"Anderson, M. A. et al. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am. J. Gastroenterol. 107, 1730\u20131739 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"42403_CR30","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdr541","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti, C. et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann. Oncol. 23, 1880\u20131888 (2012).","journal-title":"Ann. Oncol."},{"key":"42403_CR31","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cgh.2014.01.038","volume":"12","author":"A Alsamarrai","year":"2014","unstructured":"Alsamarrai, A., Das, S. L. M., Windsor, J. A. & Petrov, M. S. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol. 12, 1635\u201344e5 (2014). quiz e103.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"42403_CR32","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/jama.2009.886","volume":"301","author":"D Li","year":"2009","unstructured":"Li, D. et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301, 2553\u20132562 (2009).","journal-title":"JAMA"},{"key":"42403_CR33","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ijc.22535","volume":"120","author":"SC Larsson","year":"2007","unstructured":"Larsson, S. C., Orsini, N. & Wolk, A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int. J. Cancer. 120, 1993\u20131998 (2007).","journal-title":"Int. J. Cancer"},{"key":"42403_CR34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari, S. T. et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129, 504\u2013511 (2005).","journal-title":"Gastroenterology"},{"key":"42403_CR35","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","volume":"57","author":"Y Huang","year":"2014","unstructured":"Huang, Y. et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261\u20132269 (2014).","journal-title":"Diabetologia"},{"key":"42403_CR36","doi-asserted-by":"publisher","first-page":"e0134321","DOI":"10.1371\/journal.pone.0134321","volume":"10","author":"S Song","year":"2015","unstructured":"Song, S. et al. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. PLoS One. 10, e0134321 (2015).","journal-title":"PLoS One"},{"key":"42403_CR37","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/cncr.28863","volume":"120","author":"JL Humphris","year":"2014","unstructured":"Humphris, J. L. et al. Clinical and pathologic features of familial pancreatic cancer. Cancer 120, 3669\u20133675 (2014).","journal-title":"Cancer"},{"key":"42403_CR38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1200\/JCO.2006.09.2452","volume":"25","author":"W Wang","year":"2007","unstructured":"Wang, W. et al. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J. Clin. Oncol. 25, 1417\u20131422 (2007).","journal-title":"J. Clin. Oncol."},{"key":"42403_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaoncol.2019.5963","volume":"6","author":"M Rainone","year":"2020","unstructured":"Rainone, M., Singh, I., Salo-Mullen, E. E., Stadler, Z. K. & O\u2019Reilly, E. M. An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review. JAMA Oncol. 6, 764\u2013771 (2020).","journal-title":"JAMA Oncol."},{"key":"42403_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts, N. J. et al. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov. 6, 166\u2013175 (2016).","journal-title":"Cancer Discov"},{"key":"42403_CR41","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","volume":"35","author":"K Shindo","year":"2017","unstructured":"Shindo, K. et al. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. J. Clin. Oncol. 35, 3382\u20133390 (2017).","journal-title":"J. Clin. Oncol."},{"key":"42403_CR42","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.dld.2023.02.023","volume":"55","author":"Y Nodari","year":"2023","unstructured":"Nodari, Y. et al. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Dig. Liver Disease. 55, 1417\u20131425 (2023).","journal-title":"Dig. Liver Disease"},{"key":"42403_CR43","doi-asserted-by":"publisher","first-page":"693933","DOI":"10.3389\/fgene.2021.693933","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu, Y. et al. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Front. Genet. 12, 693933 (2021).","journal-title":"Front. Genet."},{"key":"42403_CR44","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/carcin\/bgw080","volume":"37","author":"C Rizzato","year":"2016","unstructured":"Rizzato, C. et al. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Carcinogenesis 37, 957\u2013964 (2016).","journal-title":"Carcinogenesis"},{"key":"42403_CR45","doi-asserted-by":"publisher","first-page":"104020","DOI":"10.1016\/j.critrevonc.2023.104020","volume":"186","author":"D Campa","year":"2023","unstructured":"Campa, D. et al. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years\u2019 experience of association studies to understand the genetic architecture of pancreatic cancer. Crit. Rev. Oncol. Hematol. 186, 104020 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"42403_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12920-021-00956-5","volume":"14","author":"MN Aoki","year":"2021","unstructured":"Aoki, M. N. et al. Susceptibility loci for pancreatic cancer in the Brazilian population. BMC Med. Genomics. 14, 111 (2021).","journal-title":"BMC Med. Genomics"},{"key":"42403_CR47","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41467-018-02942-5","volume":"9","author":"AP Klein","year":"2018","unstructured":"Klein, A. P. et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat. Commun. 9, 556 (2018).","journal-title":"Nat. Commun."},{"key":"42403_CR48","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy, T. et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34, 987\u20131002 (2023).","journal-title":"Ann. Oncol."},{"key":"42403_CR49","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele, F. et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann. Oncol. 31, 1491\u20131505 (2020).","journal-title":"Ann. Oncol."},{"key":"42403_CR50","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","volume":"28","author":"PA Philip","year":"2022","unstructured":"Philip, P. A. et al. Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma. Clin. Cancer Res. 28, 2704\u20132714 (2022).","journal-title":"Clin. Cancer Res."},{"key":"42403_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bjc.6600475","volume":"87","author":"F Maire","year":"2002","unstructured":"Maire, F. et al. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br. J. Cancer. 87, 551\u2013554 (2002).","journal-title":"Br. J. Cancer"},{"key":"42403_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/bjc.2016.175","volume":"115","author":"N Hadano","year":"2016","unstructured":"Hadano, N. et al. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. Br. J. Cancer. 115, 59\u201365 (2016).","journal-title":"Br. J. Cancer"},{"key":"42403_CR53","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1373\/clinchem.2016.257469","volume":"62","author":"N Brychta","year":"2016","unstructured":"Brychta, N., Krahn, T. & von Ahsen, O. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer. Clin. Chem. 62, 1482\u20131491 (2016).","journal-title":"Clin. Chem."},{"key":"42403_CR54","doi-asserted-by":"publisher","first-page":"78827","DOI":"10.18632\/oncotarget.12386","volume":"7","author":"F Le Calvez-Kelm","year":"2016","unstructured":"Le Calvez-Kelm, F. et al. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control. Oncotarget 7, 78827\u201378840 (2016).","journal-title":"Oncotarget"},{"key":"42403_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-018-1157-9","volume":"16","author":"C Fiala","year":"2018","unstructured":"Fiala, C. & Diamandis, E. P. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. BMC Med. 16, 166 (2018).","journal-title":"BMC Med."},{"key":"42403_CR56","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.ccell.2023.09.007","volume":"41","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients. Cancer Cell. 41, 1763\u20131773e4 (2023).","journal-title":"Cancer Cell."},{"key":"42403_CR57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.annonc.2022.02.007","volume":"33","author":"D Gale","year":"2022","unstructured":"Gale, D. et al. Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Ann. Oncol. 33, 500\u2013510 (2022).","journal-title":"Ann. Oncol."},{"key":"42403_CR58","first-page":"2024","volume":"383","author":"C Martin-Alonso","year":"1979","unstructured":"Martin-Alonso, C. et al. Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies. Science 383, 2024 (1979).","journal-title":"Science"},{"key":"42403_CR59","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1634\/theoncologist.2017-0467","volume":"23","author":"R Perets","year":"2018","unstructured":"Perets, R. et al. Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring. Oncologist 23, 566\u2013572 (2018).","journal-title":"Oncologist"},{"key":"42403_CR60","doi-asserted-by":"publisher","first-page":"15744","DOI":"10.1038\/s41598-024-65562-8","volume":"14","author":"T Theparee","year":"2024","unstructured":"Theparee, T. et al. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci. Rep. 14, 15744 (2024).","journal-title":"Sci. Rep."},{"key":"42403_CR61","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/clinchem\/hvac153","volume":"68","author":"JS Lee","year":"2022","unstructured":"Lee, J. S. et al. Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study. Clin. Chem. 68, 1509\u20131518 (2022).","journal-title":"Clin. Chem."},{"key":"42403_CR62","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41416-019-0704-2","volume":"122","author":"S Guo","year":"2020","unstructured":"Guo, S. et al. Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients. Br. J. Cancer. 122, 857\u2013867 (2020).","journal-title":"Br. J. Cancer"},{"key":"42403_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pan.2016.12.011","volume":"17","author":"S Ako","year":"2017","unstructured":"Ako, S. et al. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. Pancreatology 17, 285\u2013290 (2017).","journal-title":"Pancreatology"},{"key":"42403_CR64","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","volume":"6","author":"M Sausen","year":"2015","unstructured":"Sausen, M. et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat. Commun. 6, 7686 (2015).","journal-title":"Nat. Commun."},{"key":"42403_CR65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cas.14245","volume":"111","author":"M Sugimori","year":"2020","unstructured":"Sugimori, M. et al. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy. Cancer Sci. 111, 266\u2013278 (2020).","journal-title":"Cancer Sci."},{"key":"42403_CR66","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jgh3.12530","volume":"5","author":"S Takano","year":"2021","unstructured":"Takano, S. et al. Digital next-generation sequencing of cell-free DNA for pancreatic cancer. JGH Open. 5, 508\u2013516 (2021).","journal-title":"JGH Open."},{"key":"42403_CR67","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.3390\/cancers13143378","volume":"13","author":"J Milin-Lazovic","year":"2021","unstructured":"Milin-Lazovic, J. et al. Meta-Analysis of Circulating Cell-Free DNA\u2019s Role in the Prognosis of Pancreatic Cancer. Cancers (Basel). 13, 3378 (2021).","journal-title":"Cancers (Basel)"},{"key":"42403_CR68","doi-asserted-by":"crossref","unstructured":"Watanabe, K. et al. Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer. Int J. Mol. Sci 23(19), 11521, (2022).","DOI":"10.3390\/ijms231911521"},{"key":"42403_CR69","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neo.2021.06.005","volume":"23","author":"KE Affolter","year":"2021","unstructured":"Affolter, K. E. et al. Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia 23, 859\u2013869 (2021).","journal-title":"Neoplasia"},{"key":"42403_CR70","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12885-024-12463-8","volume":"24","author":"T Bardol","year":"2024","unstructured":"Bardol, T. et al. Early detection of pancreatic cancer by liquid biopsy \u2018PANLIPSY\u2019: a french nation-wide study project. BMC Cancer. 24, 709 (2024).","journal-title":"BMC Cancer"},{"key":"42403_CR71","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung, D. C. et al. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening. N Engl. J. Med. 390, 973\u2013983 (2024).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42403-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:02:03Z","timestamp":1776819723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42403-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42403"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42403-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13103"}}